Research Projects
The inhibition of DSTYK as the basis of a new targeted therapy to break resistance to standard treatments in lung cancer
Researcher | Principal Investigator
Therapeutic Innovation in Lung Cancer research group
Research Division
Cancer Division
Research group
Therapeutic innovation in lung cancer
Project information
Research project called “The inhibition of DSTYK as the basis of a new targeted therapy to break resistance to standard treatments in lung cancer” and belonging to the group Therapeutic innovation in lung cancer of the Cima University of Navarra.
- Convocation: 2023 AES Proyectos de Investigación
- Reference: PI23/00223
- Start date: January 1, 2024
- End date: December 31, 2026
- Funder: Instituto de Salud Carlos III
- Nature of project: National
- Award year 2023
Need more information?
If you are interested in learning more about our research, please contact us.